Studies how nutrition and body makeup relate to outcomes in bowel inflammation
Observes how nutrition and body composition relate to outcomes in inflammatory bowel disease.
Plain-language title generated from the registry record
Registry title: Nutrition and Clinical Outcomes in IBD
Key facts
- Where
- London, United KingdomSee the site
Where in United Kingdom
- Barts Health NHS TrustLondon, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Barts & The London NHS Trust
- Trial code
- NCT06550310
- Record updated
- 19 February 2026
- Original description
The goal of this observational study is to demonstrate that nutritional status and body composition have an impact on clinical outcomes in inflammatory bowel disease (IBD).Read full original descriptionShow less
Nutrition and Body Composition and Association With Clinical Outcomes in Inflammatory Bowel Disease
The goal of this observational study is to demonstrate that nutritional status and body composition have an impact on clinical outcomes in inflammatory bowel disease (IBD).
The main objectives are:
1. To compare the detection rates of undernutrition between a range of nutritional screening tools, physiological measures and assessment tools amongst patients with different IBD phenotypes 2. To correlate nutritional status, nutritional biomarkers and body composition with clinical outcomes in patients with IBD treated with advanced medical therapy or surgery 3. To determine a potential relationship between radiological muscle mass measurements and clinical outcomes in patients with IBD treated with advanced medical therapy or surgery
Participants will undergo an assessment at pre-treatment baseline and then again at their scheduled follow-up. This is a non-interventional study and participants will not be required to have any invasive tests or hospital visits beyond that of standard clinical care.
Inclusion: Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) starting a new advanced medical therapy; Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) undergoing an IBD-related surgery; Age >16; Patients able and willing to provide written informed consent.
Exclusion: Patients with a cardiac pacemaker or internal defibrillator; Patients with active cancer and other disorders associated with severe cachexia; Patients below the age of 16; Patients who cannot provide informed consent.